1. Home
  2. ATRC vs FORTY Comparison

ATRC vs FORTY Comparison

Compare ATRC & FORTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • FORTY
  • Stock Information
  • Founded
  • ATRC 2000
  • FORTY 1985
  • Country
  • ATRC United States
  • FORTY Israel
  • Employees
  • ATRC N/A
  • FORTY N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • FORTY EDP Services
  • Sector
  • ATRC Health Care
  • FORTY Technology
  • Exchange
  • ATRC Nasdaq
  • FORTY Nasdaq
  • Market Cap
  • ATRC 1.1B
  • FORTY 1.3B
  • IPO Year
  • ATRC 2005
  • FORTY 1997
  • Fundamental
  • Price
  • ATRC $35.34
  • FORTY $87.50
  • Analyst Decision
  • ATRC Strong Buy
  • FORTY
  • Analyst Count
  • ATRC 9
  • FORTY 0
  • Target Price
  • ATRC $41.78
  • FORTY N/A
  • AVG Volume (30 Days)
  • ATRC 465.9K
  • FORTY 421.0
  • Earning Date
  • ATRC 02-13-2025
  • FORTY 11-21-2024
  • Dividend Yield
  • ATRC N/A
  • FORTY 1.52%
  • EPS Growth
  • ATRC N/A
  • FORTY 18.72
  • EPS
  • ATRC N/A
  • FORTY 4.83
  • Revenue
  • ATRC $447,573,000.00
  • FORTY $2,706,303,000.00
  • Revenue This Year
  • ATRC $17.75
  • FORTY N/A
  • Revenue Next Year
  • ATRC $13.44
  • FORTY N/A
  • P/E Ratio
  • ATRC N/A
  • FORTY $17.15
  • Revenue Growth
  • ATRC 17.56
  • FORTY 2.60
  • 52 Week Low
  • ATRC $18.94
  • FORTY $60.39
  • 52 Week High
  • ATRC $39.05
  • FORTY $96.50
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 61.92
  • FORTY 46.15
  • Support Level
  • ATRC $31.00
  • FORTY $80.15
  • Resistance Level
  • ATRC $36.15
  • FORTY $87.46
  • Average True Range (ATR)
  • ATRC 1.50
  • FORTY 0.70
  • MACD
  • ATRC 0.55
  • FORTY -0.93
  • Stochastic Oscillator
  • ATRC 88.19
  • FORTY 47.35

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is a holding company that, through its subsidiaries, provides information technology services. The company organizes itself into operating segments: The Matrix segment, which generates the majority of revenue, provides software development and existing software expansion services. The Sapiens segment provides software development services for the insurance industry. The Magic Software segment provides vendor management systems and workforce management services, which include accounting and finance, human resources; Michpal; ZAP Group and Others. The majority of the company's revenue comes from Israel.

Share on Social Networks: